TrialNeuro-oncology2019

Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.

Julia Furtner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.